Literature DB >> 29153288

Miltefosine-based regimen as salvage therapy in Lomentospora prolificans bone and joint infection.

L Quaesaet1, E Stindel2, F Lanternier3, T Williams2, S Jaffuel4, E Moalic5, D Garcia Hermoso6, O Lortholary7, S Ansart4.   

Abstract

Entities:  

Keywords:  Bone and joint infection; Infection ostéoarticulaire; Lomentospora prolificans; Miltefosine; Miltéfosine

Mesh：

Substances：

Year:  2017        PMID： 29153288     DOI： 10.1016/j.medmal.2017.10.005

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN： 0399-077X            Impact factor:   2.152


× No keyword cloud information.
  3 in total

1.  Efficacy of Azithromycin and Miltefosine in Experimental Systemic Pythiosis in Immunosuppressed Mice.

Authors:  Erico S Loreto; Juliana S M Tondolo; Francielli P K de Jesus; Camila M Verdi; Carla Weiblen; Maria I de Azevedo; Glaucia D Kommers; Janio M Santurio; Régis A Zanette; Sydney H Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 2.  Lomentospora prolificans: An Emerging Opportunistic Fungal Pathogen.

Authors:  Afroditi Konsoula; Constantinos Tsioutis; Ioulia Markaki; Michail Papadakis; Aris P Agouridis; Nikolaos Spernovasilis
Journal:  Microorganisms       Date:  2022-06-29

3.  Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box.

Authors:  Gina Wall; Natalia Herrera; José L Lopez-Ribot
Journal:  J Fungi (Basel)       Date:  2019-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.